
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis
Author(s) -
Marouf Alhalabi,
Kamal Alaa Eddin,
Fadwa Ali,
Ahmad Abbas
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028722
Subject(s) - medicine , infliximab , ulcerative colitis , azathioprine , gastroenterology , pneumonia , colitis , inflammatory bowel disease , colectomy , surgery , tumor necrosis factor alpha , disease